Former President and Chief Executive Officer · MAXCYTE, INC. (MXCT)

Doug Doerfler

A named executive officer of MAXCYTE in every fiscal year CompBrief holds from FY2020 to FY2023. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2023

$3,136,284

Salary $641,300Stock awards $0

FY2022: $1,575,317

1st of 3 named executive officers at Maxcyte by FY2023 total.

3 named officers on file for MAXCYTE, FY2023

Doug Doerfler’s pay file — $29

  • 4 fiscal years of pay, line by line

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how MAXCYTE’s whole pay program stands against its peers

  • MAXCYTE’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on MXCT→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 26, 2024 (DEF 14A).

Free

Get Doug Doerfler’s full pay file as a PDF — free

More than this page: up to 10 years of Doug’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Doug Doerfler compensation by year

MAXCYTE Summary Compensation Table · all 4 fiscal years held
In US dollars, as MAXCYTE reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2020FY2021FY2022FY2023
Salary$518,000$575,000$605,000$641,300
Bonus$0$0$0$0
Stock awards$0$0$0$0
Option awards$332,263$646,382$375,679$797,936
Non-equity incentive$356,125$800,037$576,000$572,100
Pension and deferred compensation$0$0$0$0
All other$17,339$15,505$18,638$1,124,948
Total$1,223,727$2,036,924$1,575,317$3,136,284

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: MAXCYTE, INC. DEF 14A filed April 26, 2024, accession 0001104659-24-053089, and prior-year filings. Open the filing on EDGAR.

How this page was built: the MAXCYTE, INC. filed document, accession 0001104659-24-053089. Every figure is read from that document and cited to the page and table it appears in. Filed April 26, 2024.

$1.2M
$2.0M
$1.6M
$3.1M
FY20
FY21
FY22
FY23
SalaryNon-equity incentiveOption awardsAll other

Equity holdings

unvested awards at FY2023 year-end
TypeUnvested unitsValue at year-endExercise price
Option281,250—$7.12
Option8,129—$1.81
Option400,000—$4.19
Option113,808—$14.46
Option4,167—$16.63

Per the Outstanding Equity Awards at Fiscal Year-End table in MAXCYTE, INC.'s FY2023 proxy; value at the fiscal year-end close, as the company printed it.

MAXCYTE’s named executive officers, FY2023

as the company reported each
Named executive officerRoleFY2023 total
Doug Doerfler · this pageFormer President and Chief Executive Officer$3,136,284
Douglas SwirskyChief Financial Officer$1,189,934
Maher MasoudPresident and Chief Executive Officer, former Executive Vice President$890,365

The full MAXCYTE compensation record

free company brief

This page is one person within MAXCYTE's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are MAXCYTE's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Doug Doerfler's compensation dossier · One-time report. No refunds.